QHL-1618
QHL-1618 is a tumor microenvironment-activated drug conjugate. QHL-1618 inhibits the tumor growth in various tumor models, such as HT-1080 xenograft, CT-26 xenograft[1].
Product Specifications
CAS Number
[3106015-71-5]
UNSPSC
12352211
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C(C=C1)N(C1=O)CCC(N[C@@H](CCC(NCCOCCOCCOCCOCCOCCOCCOCCOC)=O)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CC(N)=O)C(NCOCC(N[C@H]2CCC3=C4C2=C5C(C(N6C5)=CC([C@@](O)(CC)C(OC7)=O)=C7C6=O)=NC4=CC(F)=C3C)=O)=O)=O)=O)=O)=O
Molecular Formula
C66H90FN11O23
Molecular Weight
1424.48
References & Citations
[1]Yuan Liu, et al. Tumor microenvironment-activated drug conjugate and antibody-drug conjugate. Patent. WO2025130991A1
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7054428 Inquire
Recombinant Escherichia coli O1:K1 / APEC Protoheme IX farnesyltransferase (cyoE), partial
Ask
View Details 